Trials Sponsors Conditions Drugs Pricing

Conditions

Maxillary Cyst

Outcome Measures

Primary Outcomes (1)

Post- operative pain assessment
Pain scores will be recorded on visual analog scale (VAS) using a 0 to 10 pain score basis with 0 being no pain and 10 being the worst pain the patient had ever experienced.(record will be every 24h for 7 days)
From First 24 hours after The procedure till 7 days

Secondary Outcomes (1)

Radiographic assessment
From baseline to 3 and 6 months after the operation day

Study Arms (2)

Group A

ACTIVE COMPARATOR

About 10 patients who will be subjected to low intensity diode laser "soft-laser SL202" ("PERTO LASER", pr. Stachek, 47, Saint Petersburg, Russia) before surgery (two times / week for two weeks) and then following surgery (for three times per week for four weeks).

Procedure: low level laser treatment

Group B

ACTIVE COMPARATOR

About 10 patients who will undergo conventional surgical enucleation of intra-body maxillary cystic lesions.

Procedure: low level laser treatment

Interventions

low level laser treatmentProcedure

to evaluate the effect of low-level laser therapy (LLLT) bone healing when used prior and following enucleation of intra-body maxillary cystic lesions

Also known as: Maxillary cystic enucleation

Group AGroup B

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age20 Years - 50 Years

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64)

You may qualify if:

\- patients (class I category according to American society of anesthesiologists) over 20 years and under 50 years of age, of either gender who are seeking cyst enucleation of painful intra-body maxillary cystic lesions 3 x 4 cm in size.

You may not qualify if:

Sponsors & Collaborators

Minia University
Otherlead

Study Sites (1)

Faculty of Dentistry, Minia University

Minya, 2431412, Egypt

Study Officials

TAREK ABDELBARY, Lecturer
Faculty of Dentistry, Minia University
PRINCIPAL INVESTIGATOR

Enrollment

20 participants (actual enrollment reported by the registry).

Study Design

Study Type: interventional
Phase: not applicable
Allocation: RANDOMIZED
Masking: DOUBLE
Who Masked: PARTICIPANT, INVESTIGATOR
Purpose: TREATMENT
Intervention Model: PARALLEL
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Lecturer of Oral and Maxillofacial Surgery

Study Record Dates

First Submitted

December 28, 2024

First Posted

January 6, 2025

Study Start

February 1, 2024

Actual (reported)

Impact of Photobiomodulation Bone Healing Following Cystic Enucleation

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Study Arms (2)

Group A

Group B

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

Study Officials

Enrollment

Study Design

Study Record Dates

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Study Arms (2)

Group A

Group B

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

Study Officials

Enrollment

Study Design

Study Record Dates

Source record

Locations